Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8806053rdf:typepubmed:Citationlld:pubmed
pubmed-article:8806053lifeskim:mentionsumls-concept:C0009368lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C0332853lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C0086140lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C0015376lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C0032521lld:lifeskim
pubmed-article:8806053lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:8806053pubmed:issue3lld:pubmed
pubmed-article:8806053pubmed:dateCreated1997-3-3lld:pubmed
pubmed-article:8806053pubmed:abstractTextA new tissue repair agent, RGTA11, is described for its ability to enhance colonic anastomosis repair and resistance to leakage. RGTA11 is a dextran derivative containing 110% carboxymethyl groups, 2.6% carboxymethyl benzylamide groups, and 36.6% carboxymethyl benzylamide sulfonate groups. RGTA11 was deemed efficient to protect the heparin-binding growth factors FGF2 against trypsin digestion. By this property RGTA11 mimicked heparin or heparan sulfate. We have also found that RGTA11 protected TGF beta 1 against trypsin digestion while heparin did not. RGTA11 was then tested in an in vivo wound-healing model of colonic anastomosis. Our results indicate that after 48 h, RGTA11- or RGTA11/FGF-2-treated animals presented a resistance of the anastomosis to leakage which was increased twofold (p < 0.05) over untreated controls. After 96 h and until day 7 there was no more difference with control animals. Our results suggest that RGTA11 presents potential clinical interest by preventing earlier leakage of colonic anastomosis.lld:pubmed
pubmed-article:8806053pubmed:languageenglld:pubmed
pubmed-article:8806053pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8806053pubmed:citationSubsetIMlld:pubmed
pubmed-article:8806053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8806053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8806053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8806053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8806053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8806053pubmed:statusMEDLINElld:pubmed
pubmed-article:8806053pubmed:monthJullld:pubmed
pubmed-article:8806053pubmed:issn0021-9304lld:pubmed
pubmed-article:8806053pubmed:authorpubmed-author:BenoitJJlld:pubmed
pubmed-article:8806053pubmed:authorpubmed-author:BarritaultDDlld:pubmed
pubmed-article:8806053pubmed:authorpubmed-author:SézeurAAlld:pubmed
pubmed-article:8806053pubmed:authorpubmed-author:AyoubNNlld:pubmed
pubmed-article:8806053pubmed:authorpubmed-author:MeddahiAAlld:pubmed
pubmed-article:8806053pubmed:issnTypePrintlld:pubmed
pubmed-article:8806053pubmed:volume31lld:pubmed
pubmed-article:8806053pubmed:ownerNLMlld:pubmed
pubmed-article:8806053pubmed:authorsCompleteYlld:pubmed
pubmed-article:8806053pubmed:pagination293-7lld:pubmed
pubmed-article:8806053pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:meshHeadingpubmed-meshheading:8806053-...lld:pubmed
pubmed-article:8806053pubmed:year1996lld:pubmed
pubmed-article:8806053pubmed:articleTitleHeparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage.lld:pubmed
pubmed-article:8806053pubmed:affiliationLaboratoire de Recherche sur la Croissance, la Réparation et la Régénération Tissulaire (CRRET), CNRS URA 1813, Université Paris XII-Val de Marne, Créteil, France.lld:pubmed
pubmed-article:8806053pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8806053pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8806053lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8806053lld:pubmed